Elsevier

HPB

Volume 13, Issue 1, January 2011, Pages 59-63
HPB

Original Articles
Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors

https://doi.org/10.1111/j.1477-2574.2010.00242.xGet rights and content
Under an Elsevier user license
open archive

Abstract

Background

Intrahepatic cholangiocarcinoma (ICC) remains a rare tumour, although its incidence is increasing. Surgical resection is the mainstay of treatment. Published data regarding prognostic factors and optimal patient selection for resection are scant. We sought to determine the clinicopathologic characteristics of resectable ICC and outcomes following surgical treatment.

Methods

We reviewed prospectively collected clinical data including patient, pathologic and operative details. Survival and recurrence outcomes were analysed using Cox hazard models and the Kaplan–Meier method.

Results

We identified 31 surgically treated patients. Their 3-year overall survival rate (OS) was 40.1%; median follow-up was 16.2 months (range: 0.2–86.9 months). R0 resection was associated with significantly improved OS compared with R1/R2 resection (3-year OS was 68.6% in R0 vs. 24.0% in R1/R2; P= 0.042). The postoperative complication rate was 58.1%. Two patients died of postoperative liver failure within 30 days. Preoperative hypoalbuminaemia was significantly associated with worse survival.

Conclusions

Surgical therapy for ICC is associated with longterm survival in the subset of nutritionally replete patients in whom an R0 resection can be achieved. Surgical mortality is significant in patients undergoing extended resection. The margin involvement rate is high and surgeons should consider the infiltrative nature of the disease in operative planning.

Keywords

cholangiocarcinoma < liver
resection < cholangiocarcinoma
outcomes < cholangiocarcinoma

Cited by (0)

This paper was presented at the International Hepato-Pancreato-Biliary Association Annual Meeting, 18–22 April 2010, Buenos Aires, Argentina.